AUS
NZ
UK
CA
USA
IND
_07_03_2026_03_50_21_133108.jpg)
_02_06_2025_07_05_23_538703.jpg)
Morgan Stanley Finance LLC has launched a new structured investment product providing leveraged exposure to U.S. equities via buffered notes linked to the S&P 500 Index. Priced at $1,000 per note with an estimated trade-date value near $985.40, these notes offer investors 150% participation in positive index returns while shielding principal losses up to 7.50%. This issuance expands Morgan Stanley's Series A Global Medium-Term Notes program, targeting investors seeking amplified equity market gains alongside defined risk limits.
Key Points
- NYSE ticker: MS-PQ
- Morgan Stanley Finance LLC introduced Leveraged Buffered S&P 500 Index-Linked Notes maturing between 17 and 20 months from trade date
- Notes provide 150% upside participation in positive S&P 500 returns, capped between $1,184.20 and $1,216.00 per $1,000 face value
- Full principal protection if S&P 500 declines up to 7.50%; losses occur if decline exceeds 7.50%
Structure and Index Linkage Details
These notes combine leveraged upside exposure with a downside buffer, designed for investors seeking enhanced returns during rising markets while retaining partial capital protection during moderate downturns. They are unsecured obligations of Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, relying on the parent company’s creditworthiness. Performance is linked to the S&P 500 Index from trade date to a determination date approximately 17 to 20 months later.
Pricing reflects both a debt component and performance-based payoff tied to the index. Morgan Stanley set the 150% upside participation and cap levels using an internal funding rate likely below its secondary market credit spreads. This internal rate impacts terms offered, with disclosures noting that lower issuance costs or higher funding rates would yield more favorable terms for investors.
Leverage and Return Calculation Methodology
The notes amplify positive S&P 500 returns by 150%, subject to a maximum settlement cap ranging from $1,184.20 to $1,216.00 per $1,000 invested, equating to roughly 18.4% to 21.6% maximum gains. If the index rises above the initial level at the determination date, investors receive $1,000 plus 150% of the index gain, capped accordingly.
Return calculations follow a formula disclosed in the prospectus supplement: principal recovery plus leveraged index return, capped at the maximum settlement amount. This payoff structure limits issuer liability while offering defined upside potential.
Downside Buffer and Loss Thresholds
Investors benefit from a buffer protecting full principal if the S&P 500 falls no more than 7.50% from the initial level, ensuring return of the $1,000 investment within this decline range. This feature aims to provide confidence against typical market corrections.
If the index declines beyond 7.50%, losses are calculated proportionally using a disclosed formula multiplying approximately 1.0811 times the sum of the index return plus 7.50%, applied to $1,000. This structure exposes investors to full loss of principal if the index declines sufficiently, emphasizing the principal-at-risk nature despite the buffer.
Issuance Pricing and Estimated Trade-Date Value
Notes are issued at $1,000 each, with Morgan Stanley & Co. charging an agent commission of $11.20 per note (1.12% of face value). The estimated trade-date value is about $985.40, reflecting a $14.60 discount per $1,000 due to issuance, sales, structuring, and hedging costs borne by investors upfront.
This valuation incorporates Morgan Stanley’s pricing models, market inputs, volatility, interest rates, and credit spreads. Secondary market prices may differ due to bid-offer spreads and market changes. For up to three months post-issuance, secondary market prices may exceed the estimated trade-date value as some costs amortize over time.
Credit Risk and Guarantee Information
The notes carry credit risk linked to Morgan Stanley Finance LLC and are fully guaranteed by Morgan Stanley. Payments depend on Morgan Stanley’s creditworthiness; default could result in partial or total loss. As unsecured obligations, notes lack collateral or asset backing, exposing investors to counterparty risk alongside market risk.
The guarantee binds the parent company to the subsidiary’s obligations but does not alter credit exposure. These notes are not bank deposits, savings accounts, or FDIC-insured, nor guaranteed by banks other than Morgan Stanley entities, which is important for investors expecting deposit protections.
Secondary Market Liquidity and Distribution
Morgan Stanley & Co. acts as sole initial purchaser, reselling notes to unaffiliated dealers who receive a 1.12% sales commission. MS & Co. may but is not required to maintain a secondary market, and can cease market-making at any time, introducing liquidity risk for investors wishing to sell before maturity.
Secondary market prices, when available, will reflect bid-ask spreads, market conditions, volatility, and credit spreads, potentially trading below original purchase prices. MS & Co. may buy notes at prices above estimated trade-date value during the first three months at its discretion.
Tax and Regulatory Considerations
The preliminary pricing supplement references a tax supplement dated April 8, 2026, detailing federal income tax treatment, which investors should review alongside this disclosure. Tax implications vary by individual circumstances, so consulting tax professionals is advised.
These notes are registered under SEC filings 333-293641 and 333-293641-01, with this document filed as 424(b)(2). The SEC has neither approved nor disapproved the notes, focusing solely on disclosure adequacy. State securities regulators have similarly not approved the offering, which remains subject to final terms and completion.
Risk Factors and Investor Warnings
Risks include market risk from S&P 500 fluctuations, credit risk of Morgan Stanley, and liquidity risk due to discretionary secondary market activity. Losses can exceed the buffer if the index declines beyond 7.50%, with total capital loss possible. Leverage amplifies both gains and losses, and other risks include reinvestment, interest rate, and volatility risks.
Investors should carefully review the "Risk Factors" section starting on page 10 of the prospectus and product supplement for comprehensive risk disclosures. The filing repeatedly warns of potential total loss despite the buffer, underscoring the importance of weighing risk-return tradeoffs.
Maturity and Final Pricing Details
The notes mature 17 to 20 months after trade date, with maturity payment calculated based on the final S&P 500 Index level relative to the initial level. The exact maturity and determination dates will be finalized in the final pricing supplement.
The initial underlier level is set on trade date by Morgan Stanley’s pricing process and may differ from the published index close. The determination date for final index measurement is expected 17 to 20 months post-issuance.
Use of Proceeds and Hedging
Proceeds will be utilized as detailed in the "Use of proceeds and hedging" section on page 18 of the prospectus supplement. Morgan Stanley will engage in hedging activities related to these notes, though specifics on strategy, counterparties, or costs are not provided in this preliminary supplement. Hedging expenses influence pricing and internal funding rates.
The filing notes that lower issuance and hedging costs or higher internal funding rates would improve economic terms for investors. The initial discount from par partly reflects these embedded costs, though they are not itemized separately.
